About this trial
The primary objectives of this study are to determine whether exercise training is an effective strategy for treatment of Long COVID and characterize the cardiorespiratory and autonomic physiology in these patients to precisely characterize mechanisms contributing to this syndrome.
Eligibility criteria
Qualifiers
Adults ≥18 years with documented history of COVID-19 infection and symptoms consistent with Long COVID lasting >12 weeks after diagnosis.
Disqualifiers
History of cardiovascular/pulmonary disease prior to infection
COVID-related myocardial injury such as evidence of myocarditis
Deep vein thrombosis/pulmonary embolism following COVID-19 infection
Exercise intolerance resulting from conditions that are not related to cardiorespiratory or autonomic factors (e.g. osteoarthritis or other musculoskeletal diseases);
Trial design
Treatments tested in this trial
- Exercise